Apidra 100 Units/ml solution for injection combined
Last Updated on eMC 26-Jun-2017 View document | SANOFI Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 26-Jun-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Date of revision of text on the SPC: 16-Jun-2017
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
UpdateSPC to add the CE marked reusable pen AllStar PROUpdated on 17-May-2017 and displayed until 26-Jun-2017
Reasons for adding or updating:
- Change to legal category
Date of revision of text on the SPC: 05-Jan-2017
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Updated to POM
Updated on 05-Apr-2017 and displayed until 17-May-2017
Reasons for adding or updating:
- Improved presentation of SPC
Date of revision of text on the SPC: 31-Mar-2017
Legal Category:P
Black Triangle (CHM): NO
Updated on 30-Mar-2017 and displayed until 05-Apr-2017
Reasons for adding or updating:
- New individual SPC (was previously included in joint SPC)
- Submitted in error
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Apidra 100 Units/ml solution for injection now combined SPCSANOFI
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
+44 (0)1483 535 432
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue